|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2023―Mar―26 |
G6PD deficiency-does it alter the course of COVID-19 infections? |
Tsz Yuen Au, Oskar Wojciech Wiśniewski, Shamiram Benjamin, Tadeusz Kubicki, Dominik Dytfeld, Lidia Gil |
2 |
[GO] |
2023―Mar―25 |
Real-life experience of secondary prophylaxis with DOACs in splanchnic venous thrombosis during COVID-19 pandemic |
Luca Guarnera, Elisa Buzzatti, Fabrizio Bonanni, Giovangiacinto Paterno, Antonella Riccitelli, Vittorio Forte, et al. (+2) Adriano Venditti, Maria Ilaria Del Principe |
3 |
[GO] |
2023―Mar―02 |
Humoral response to mRNA-based COVID-19 vaccine and booster effect of a third dose in patients with mature T cell and NK-cell neoplasms |
Mirei Kobayashi, Akio Mori, Masahiro Onozawa, Shihori Tsukamoto, Hajime Senjo, Takashi Ishio, et al. (+8) Emi Yokoyama, Minoru Kanaya, Koh Izumiyama, Makoto Saito, Haruna Muraki, Masanobu Morioka, Takanori Teshima, Takeshi Kondo |
4 |
[GO] |
2023―Feb―27 |
COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group |
Martin Šimkovič, Peter Turcsányi, Martin Špaček, Jana Mihályová, Pavlína Ryznerová, Mária Maco, et al. (+18) Pavel Vodárek, Dominika Écsiová, Hynek Poul, Heidi Móciková, Jana Zuchnická, Anna Panovská, Mohammad Lekaa, Martina Oršulová, Adéla Prchlíková, Lukáš Stejskal, Stanislava Mašlejová, Yvona Brychtová, Lucie Bezděková, Tomáš Papajík, Daniel Lysák, Marek Trněný, Lukáš Smolej, Michael Doubek |
5 |
[GO] |
2023―Feb―16 |
Analysis of hematologic adverse events reported to a national surveillance system following COVID-19 bivalent booster vaccination |
Jeremy W. Jacobs, Garrett S. Booth, Brian D. Adkins |
6 |
[GO] |
2022―Dec―10 |
BRAF inhibitor treatment of classical hairy cell leukemia allows successful vaccination against SARS-CoV-2 |
Judith Konrat, Wiebke Rösler, Michael Roiss, Fabienne Meier-Abt, Corinne C. Widmer, Stefan Balabanov, et al. (+2) Markus G. Manz, Thorsten Zenz |
7 |
[GO] |
2022―Nov―24 |
Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain |
Ariana Ortuzar, María Laura Fox, Juan Antonio Vera, Álvaro Lorenzo Vizcaya, Alberto Marín Sánchez, Inmaculada Llopis Calatayud, et al. (+26) Sara Carbonell, Alberto Álvarez-Larrán, Raquel Mata Serna, Josefa E. Marco Buades, Keina Quiroz Cervantes, Ángela Martínez Hellín, Alejandra Blum Domínguez, Gonzalo Caballero Navarro, Amparo Cáceres Sansaloni, Lucía Guerrero Fernández, Cristina Muñoz Linares, Mercedes Gasior Kabat, Raúl Pérez López, Ángeles Fernández Rodríguez, Cristina Martínez Bilbao, María Teresa Cobo Rodríguez, Álvaro Díaz, M. Antonia Durán, Marta Santaliestra Tomas, Valentín García-Gutierrez, Elena Magro Mazo, Juan Carlos Hernández-Boluda, Adrián Segura, José María Raya, Begoña Navas Elorza, Santiago Osorio |
8 |
[GO] |
2022―Nov―18 |
CD19 CAR T-cell infusion during severe COVID-19 acute respiratory distress syndrome in large B-cell lymphoma |
Nina Buchtele, Philipp Wohlfarth, Thomas Staudinger, Peter Schellongowski, Ludwig Traby, Matthias Vossen, et al. (+5) Hanna Knaus, Elisabeth Lobmeyr, Werner Rabitsch, Nina Worel, Philipp B. Staber |
9 |
[GO] |
2022―Nov―12 |
New-onset Evans syndrome in a patient with SLE post SARS-CoV2 mRNA vaccination |
Timothy Y. M. Ng, Winnie Z. Y. Teo, Terence Y. M. Ng, Gim Gee Teng |
10 |
[GO] |
2022―Oct―22 |
Immunogenicity of a third dose of the BNT162b2 COVID-19 vaccine in patients with CLL: effects on treatment selection |
Panagiotis T. Diamantopoulos, Christina-Nefeli Kontandreopoulou, Christos Stafylidis, Dimitra Vlachopoulou, Nefeli Giannakopoulou, Maria Vardaka, et al. (+7) Anthi Mpouhla, Eleni Variami, Athanasios Galanopoulos, Vassiliki Pappa, Mina Psichogiou, Angelos Hatzakis, Nora-Athina Viniou |
11 |
[GO] |
2022―Aug―26 |
Amyloidosis and COVID-19: experience from an amyloid program in Canada |
Ellen Lewis, Nowell Fine, Robert J. H. Miller, Christopher Hahn, Sameer Chhibber, Etienne Mahe, et al. (+6) Jason Tay, Peter Duggan, Sylvia McCulloch, Nizar Bahlis, Paola Neri, Victor H. Jimenez-Zepeda |
12 |
[GO] |
2022―Aug―02 |
B-cell-guided strategy for SARS-CoV2 vaccination after autologous stem cell transplantation for B-cell lymphoma - a case report |
Ben-Niklas Baermann, Paul Jäger, Guido Kobbe |
13 |
[GO] |
2022―Jul―14 |
An association between a positive direct antiglobulin test and HLA-DR12 in COVID-19 |
Hideaki Matsuura, Sumie Fujii, Yusuke Matsui, Yukari Sugiura, Hidehiko Akiyama, Yasuo Miura |
14 |
[GO] |
2022―Jul―14 |
Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies |
Ferenc Magyari, László Imre Pinczés, Edit Páyer, Katalin Farkas, Szilvia Ujfalusi, Ágnes Diószegi, et al. (+6) Máté Sik, Zsófia Simon, Gergely Nagy, Zsuzsanna Hevessy, Béla Nagy, Árpád Illés |
15 |
[GO] |
2022―Jul―08 |
Hemolytic anemia in COVID-19 |
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Ajeet Kaushik, Małgorzata Kujawska, Gaber El-Saber Batiha |
16 |
[GO] |
2022―Jul―02 |
Venous thromboembolism after COVID-19 mRNA vaccination |
Philip Murphy |
17 |
[GO] |
2022―Jul―02 |
Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients |
José Luis Piñana, Pablo Rodríguez-Belenguer, Dolores Caballero, Rodrigo Martino, Lucia Lopez-Corral, María-José Terol, et al. (+26) Lourdes Vazquez, Marisa Calabuig, Gabriela Sanz-Linares, Francisca Marin-Jimenez, Carmen Alonso, Juan Montoro, Elena Ferrer, Ana Facal, María-Jesús Pascual, Alicia Rodriguez-Fernandez, María T. Olave, Almudena Cascales-Hernandez, Beatriz Gago, José-Ángel Hernández-Rivas, Lucia Villalon, Magdalena Corona, Alicia Roldán-Pérez, Julia Ribes-Amoros, Clara González-Santillana, Ramon Garcia-Sanz, David Navarro, Antonio J. Serrano-López, Ángel Cedillo, Emilio Soria-Olivas, Anna Sureda, Carlos Solano |
18 |
[GO] |
2022―Jun―20 |
Favorable outcome of SARS-CoV-2 infection in pediatric hematology oncology patients during the second and third pandemic waves in Italy: a multicenter analysis from the Infectious Diseases Working Group of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) |
Daniele Zama, Francesco Baccelli, Antonella Colombini, Amalia Contino, Elisabetta Calore, Maria Grazia Petris, et al. (+24) Linda Meneghello, Federico Mercolini, Andrea Lo Vecchio, Shana Montalto, Cristina Meazza, Angelica Barone, Francesca Compagno, Paola Muggeo, Elena Soncini, Letizia Brescia, Eugenia Giraldi, Nagua Giurici, Rosa Maria Mura, Monica Cellini, Katia Perruccio, Valeria Petroni, Milena La Spina, Ottavio Ziino, Roberta Burnelli, Raffaella De Santis, Maurizio Mascarin, Valentina Barretta, Gloria Tridello, Simone Cesaro |
19 |
[GO] |
2022―May―24 |
SARS-CoV-2 PrEP complicates antibody testing after vaccination: a call for awareness |
Malte B. Monin, Benjamin Marx, Lisa Meffert, Christoph Boesecke, Jürgen K. Rockstroh, Christian P. Strassburg, et al. (+2) Peter Brossart, Annkristin Heine |
20 |
[GO] |
2022―May―21 |
Definition of factors associated with negative antibody response after COVID-19 vaccination in patients with hematological diseases |
Jil Rotterdam, Margot Thiaucourt, Christel Weiss, Juliana Schwaab, Andreas Reiter, Sebastian Kreil, et al. (+11) Laurenz Steiner, Sebastian Fenchel, Henning D. Popp, Wolf-Karsten Hofmann, Karin Bonatz, Catharina Gerhards, Michael Neumaier, Stefan A. Klein, Sonika Rao, Mohamad Jawhar, Susanne Saussele |
21 |
[GO] |
2022―Apr―11 |
COVID-19: impact of vaccination in myeloma patients |
E. Hoornaert, F. Dachy, A. Hansenne, S. Bailly, A. van Maanen, D. Gruson, M-C. Vekemans |
22 |
[GO] |
2022―Apr―07 |
Infections with the SARS-CoV-2 Omicron variant show a similar outcome as infections with the previous variants in patients with hematologic malignancies |
Ryutaro Taenaka, Teppei Obara, Kentaro Kohno, Kenichi Aoki, Ryosuke Ogawa |
23 |
[GO] |
2022―Mar―11 |
Higher ferritin levels in COVID-19 patients are associated with hyperinflammation, worse prognosis, and more bacterial infections without pronounced features of hemophagocytosis |
Marko Lucijanic, Martina Demaria, Jelena Gnjidic, Zrinka Rob, Dora Filipovic, Toni Penovic, et al. (+9) Ana Jordan, Mislav Barisic-Jaman, Frane Pastrović, Dijana Lucijanic, Tomislav Cikara, Tomo Lucijanic, Marko Miletic, Divo Ljubicic, Tatjana Keres |
24 |
[GO] |
2022―Feb―04 |
No aggravation of congenital thrombotic thrombocytopenic purpura by mRNA-based vaccines against COVID-19: a Japanese registry survey |
Eriko Hamada, Kazuya Sakai, Shinya Yamada, Masayuki Kubo, Masaki Hayakawa, Masanori Matsumoto |
25 |
[GO] |
2022―Jan―27 |
Deep venous thrombosis and pulmonary embolism after COVID-19 mRNA vaccination |
Ali Atoui, Kawthar Jarrah, Layal Al Mahmasani, Rayan Bou-Fakhredin, Ali T. Taher |
26 |
[GO] |
2021―Dec―04 |
Hemophagocytosis, hyper-inflammatory responses, and multiple organ damages in COVID-19-associated hyperferritinemia |
Guiying Dong, Jianbo Yu, Weibo Gao, Wei Guo, Jihong Zhu, Tianbing Wang |
27 |
[GO] |
2021―Oct―18 |
ChAdOx1 nCov-19 vaccine-induced thrombotic thrombocytopenic purpura successfully treated with plasmapheresis |
Yen-Ching Wang, Tsung-Chih Chen, Chieh-Lin Jerry Teng, Cheng-Han Wu |
28 |
[GO] |
2021―Oct―13 |
Autologous hematopoietic stem cell transplantation with concomitant SARS-CoV-2 infection |
Hanna A. Knaus, W. Rabitsch, N. Buchtele, J. Cserna, P. Wohlfarth |
29 |
[GO] |
2021―Oct―01 |
Vincristine therapy for severe and refractory immune thrombocytopenia following COVID-19 vaccination |
Kei Saito, Satoshi Ichikawa, Shunsuke Hatta, Yuna Katsuoka, Hideo Harigae, Tohru Izumi |
30 |
[GO] |
2021―Sep―24 |
Clinical profile and outcome of COVID-19 in haematological malignancies: experience from tertiary care centre in India |
Anshul Gupta, Nihar Desai, Priyanka Chauhan, Soniya Nityanand, Zia Hashim, Mansi Gupta |
31 |
[GO] |
2021―Sep―22 |
Impact of rituximab on COVID-19 outcomes |
Hannah Levavi, Guido Lancman, Janice Gabrilove |
32 |
[GO] |
2021―Sep―17 |
Mortality by COVID-19 in adults with acute myeloid leukemia: a survey with hematologists in Brazil |
Evandro M. Fagundes, Naira N. Neto, Lorena M. Caldas, Jordana R. Aragão, Ana Beatriz F. Gloria, Leonardo G. Leite, et al. (+5) Paula Bastos, Carolina M. Fernandes, Mariana Chalup, Rosa Arcuri, Olivia G. Fagundes |
33 |
[GO] |
2021―Sep―13 |
Clinical characteristics and outcomes of patients with haematologic malignancies and COVID-19 suggest that prolonged SARS-CoV-2 carriage is an important issue |
Robin Arcani, Julien Colle, Raphaël Cauchois, Marie Koubi, Pierre-André Jarrot, Rodolphe Jean, et al. (+8) Arthur Boyer, Julie Lachamp, Antoine Tichadou, Anne-Laure Couderc, Laure Farnault, Regis Costello, Geoffroy Venton, Gilles Kaplanski |
34 |
[GO] |
2021―Aug―22 |
Association of blood type A with increased risk of severe COVID-19 in healthcare workers |
Niraj N. Mahajan, Rahul K. Gajbhiye, Periyasamy Kuppusamy, Shubhada Bahirat, Pradip D. Lokhande |
35 |
[GO] |
2021―Jul―26 |
Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience |
Marta Krejci, Ludek Pour, Zdenek Adam, Viera Sandecka, Martin Stork, Sabina Sevcikova, et al. (+3) Martin Krejci, Zdenka Knechtova, Zdenek Kral |
36 |
[GO] |
2021―Jul―26 |
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine |
Johannes Ruhe, Ulf Schnetzke, Karim Kentouche, Florian Prims, Michael Baier, Konstantin Herfurth, et al. (+4) Mandy Schlosser, Martin Busch, Andreas Hochhaus, Gunter Wolf |
37 |
[GO] |
2021―Jul―24 |
Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis |
Giovanni Caocci, Olga Mulas, Daniela Mantovani, Alessandro Costa, Andrea Galizia, Luca Barabino, et al. (+3) Marianna Greco, Roberta Murru, Giorgio La Nasa |
38 |
[GO] |
2021―May―25 |
Comparison of the clinical course of COVID-19 infection in sickle cell disease patients with healthcare professionals |
Can Boğa, Süheyl Asma, Göksel Leblebisatan, Nazan Şen, Anıl Tombak, Yusuf Ziya Demiroğlu, et al. (+8) Mahmut Yeral, Şule Akın, Hasan Yeşilağaç, Mehmet Ali Habeşoğlu, Anış Arıboğan, Mutlu Kasar, Aslı Korur, Hakan Özdoğu |
39 |
[GO] |
2021―Mar―08 |
Association between ABO blood types and coronavirus disease 2019 (COVID-19), genetic associations, and underlying molecular mechanisms: a literature review of 23 studies |
Yujia Zhang, Rachael Garner, Sana Salehi, Marianna La Rocca, Dominique Duncan |
40 |
[GO] |
2021―Feb―19 |
Severe warm autoimmune hemolytic anemia in COVID-19 managed with least incompatible RBC product and glucocorticoids |
Tien-Chan Hsieh, Oleg Sostin |
41 |
[GO] |
2021―Feb―02 |
Management of chronic patients during the COVID-19 pandemic: the experience of a referral center for rare hematological disorders in the hardest-hit region in Italy |
Irene Motta, Alessia Marcon, Maria Domenica Carrabba, Elena Cassinerio, Margherita Migone De Amicis, Adriana Branchi, et al. (+5) Marianna Giuditta, Diletta Maira, Giovanna Fabio, Giovanna Graziadei, Marina Baldini |
42 |
[GO] |
2021―Feb―01 |
Hematologic changes predict clinical outcome in recovered patients with COVID-19 |
Jian Mao, Rong Dai, Rui-Chan Du, Yan Zhu, Li-Ping Shui, Xiao-Hua Luo |
43 |
[GO] |
2021―Feb―01 |
COVID-19 pandemic and transfusion medicine: the worldwide challenge and its implications |
Layal Al Mahmasani, Mohammad Hassan Hodroj, Antoine Finianos, Ali Taher |
44 |
[GO] |
2021―Jan―18 |
HSV1 viremia with fulminant hepatitis as opportunistic sequela in severe COVID-19 |
Luca Roncati, Antonio Manenti, Luca Fabbiani, Claudia Malagoli, Vincenzo Nasillo, Beatrice Lusenti, et al. (+6) Massimo Lupi, Giuliana Zanelli, Tiziana Salviato, Matteo Costantini, Tommaso Trenti, Antonio Maiorana |
45 |
[GO] |
2021―Jan―07 |
Hematologic disorders associated with COVID-19: a review |
Mandeep Singh Rahi, Vishal Jindal, Sandra-Patrucco Reyes, Kulothungan Gunasekaran, Ruby Gupta, Ishmael Jaiyesimi |
46 |
[GO] |
2020―Nov―17 |
Questioning the association between ABO type and outcomes in patients with COVID-19 |
Jori E. May, Gerald McGwin, Radhika Gangaraju, Rita Paschal, Kaci Weaver, Jose L. O. Lima, Marisa B. Marques |
47 |
[GO] |
2020―Nov―13 |
Blood and platelet transfusion from a donor with presymptomatic Covid-19 |
Konstantinos Liapis, Menelaos Papoutselis, Georgios Vrachiolias, Christina Misidou, Emmanouil Spanoudakis, Zoe Bezirgiannidou, et al. (+3) Aikaterini Pentidou, Theocharis Konstantinidis, Ioannis Kotsianidis |
48 |
[GO] |
2020―Nov―10 |
Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report |
Hannah Schüller, Franziska Klein, Michael Lübbert, Eric Peter Prager |
49 |
[GO] |
2020―Nov―07 |
COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry |
Maria Madeleine Rüthrich, C. Giessen-Jung, S. Borgmann, A. Y. Classen, S. Dolff, B. Grüner, et al. (+15) F. Hanses, N. Isberner, P. Köhler, J. Lanznaster, U. Merle, S. Nadalin, C. Piepel, J. Schneider, M. Schons, R. Strauss, L. Tometten, J. J. Vehreschild, M. von Lilienfeld-Toal, G. Beutel, K. Wille |
50 |
[GO] |
2020―Nov―06 |
Plasma hemoglobin in COVID-19: authors’ reply |
Guido Lancman, Bridget K. Marcellino, Santiago Thibaud, Kevin Troy |
51 |
[GO] |
2020―Oct―20 |
Characteristics of coagulation alteration in patients with COVID-19 |
Hong-chun Luo, Cheng-yan You, Si-wei Lu, Yue-qiang Fu |
52 |
[GO] |
2020―Oct―07 |
Coagulopathy and thromboembolic events in patients with
SARS-CoV-2 infection: pathogenesis and management strategies |
Alessandro Allegra, Vanessa Innao, Andrea Gaetano Allegra, Caterina Musolino |
53 |
[GO] |
2020―Sep―24 |
Elevated plasma hemoglobin in COVID-19-related illnesses: a critical appraisal |
Nishant R. Tiwari, Nagnath K. Redewad, Apurva A. Ketkar, Vivek R. Sharma |
54 |
[GO] |
2020―Sep―12 |
Prognostic significance of hemoglobin level and autoimmune hemolytic anemia in SARS-CoV-2 infection |
Abdulrahman A. Algassim, Assem A. Elghazaly, Abdulrahman S. Alnahdi, Owais M. Mohammed-Rahim, Abdulaziz G. Alanazi, Nawaf A. Aldhuwayhi, et al. (+5) Mashael M. Alanazi, Mohammed F. Almutairi, Ibrahim M. Aldeailej, Najeeb A. Kamli, Mahmoud D. Aljurf |
55 |
[GO] |
2020―Aug―28 |
High density of IgG4-secreting plasma cells in the fibrotic tissue from a surgically resected tracheal ring impaired by complex subglottic stenosis post-tracheostomy as immune expression of a Th2 response due to severe COVID-19 |
Luca Roncati, Giuliano Bergonzini, Beatrice Lusenti, Vincenzo Nasillo, Ambra Paolini, Giuliana Zanelli, Stefania Corrado |
56 |
[GO] |
2020―Aug―17 |
Thrombotic complications and anticoagulation in COVID-19 pneumonia: a New York City hospital experience |
Ahmad Hanif, Sumera Khan, Nikhitha Mantri, Sana Hanif, Muhamed Saleh, Yamini Alla, et al. (+6) Siddharth Chinta, Nikee Shrestha, Wenyan Ji, Kristopher Attwood, Muhammad Adrish, Kevin R. Jain |
57 |
[GO] |
2020―Aug―01 |
Coombs-negative hemolytic anemia and elevated plasma hemoglobin levels in COVID-19 |
Guido Lancman, Bridget K. Marcellino, Santiago Thibaud, Kevin Troy |
58 |
[GO] |
2020―Jul―18 |
COVID-19 infection in patients with multiple myeloma: a German-Chinese experience from Würzburg and Wuhan |
Xiang Zhou, Tao Bai, Katharina Meckel, Jun Song, Yu Jin, K. Martin Kortüm, et al. (+3) Hermann Einsele, Xiaohua Hou, Leo Rasche |
59 |
[GO] |
2020―Jul―18 |
Thrombocytopenia in COVID-19: pathophysiology matters |
Eleni Gavriilaki, Ioanna Sakellari, Maria Gavriilaki, Achilles Anagnostopoulos |
60 |
[GO] |
2020―Jul―12 |
Blood type and outcomes in patients with COVID-19 |
Christopher A. Latz, Charles DeCarlo, Laura Boitano, C. Y. Maximilian Png, Rushad Patell, Mark F. Conrad, et al. (+2) Matthew Eagleton, Anahita Dua |
61 |
[GO] |
2020―Jun―29 |
Measures for preventing nosocomial infection with SARS-CoV-2 in hematology departments |
Yingying Wang, Jingfeng Li, Li Liu, Jianfang Li, Xiaoyan Liu, Jing He, et al. (+4) Cong Wang, Dan Ye, Xinghuan Wang, Fuling Zhou |
62 |
[GO] |
2020―Jun―26 |
SARS-CoV-2-associated cold agglutinin disease: a report of two cases |
Tessa Huscenot, Joris Galland, Margot Ouvrat, Mathias Rossignol, Stéphane Mouly, Damien Sène |
63 |
[GO] |
2020―Jun―25 |
IL-1R blockade is not effective in patients with hematological malignancies and severe SARS-CoV-2 infection |
Carolina Villegas, María Poza, Paloma Talayero, José Manuel Caro Teller, Denis Zafra, Cristina Garcia, et al. (+9) Elena Vera, Marta Hidalgo, Nieves Lopez, Clara Cuellar, Irene Zamanillo, Rodrigo Íñiguez, Estela Paz-Artal, José M. Aguado, J. Martinez-Lopez |
64 |
[GO] |
2020―Jun―24 |
COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure |
Monia Marchetti |
65 |
[GO] |
2020―Jun―23 |
COVID-19, impact on myeloma patients |
Inès Dufour, Juliette Raedemaeker, Fabio Andreozzi, Géraldine Verstraete, Sarah Bailly, Michel Delforge, et al. (+13) Pauline Storms, Caroline Jacquy, Ann Van de Velde, Philippe Mineur, Marie Lejeune, Deborah Bauwens, Florence Van Obbergh, Alain Kentos, Jasmine Nguyen, Karel Fostier, Anne De Weweire, Nathalie Meuleman, Marie-Christiane Vekemans |
66 |
[GO] |
2020―Jun―16 |
COVID-19 infection associated with autoimmune hemolytic anemia |
Antoine Capes, Sarah Bailly, Philippe Hantson, Ludovic Gerard, Pierre-François Laterre |
67 |
[GO] |
2020―Jun―13 |
COVID-19 presenting as neutropenic fever |
Hunter C. Spencer, Riana Wurzburger |
68 |
[GO] |
2020―Jun―13 |
SARS-CoV-2 impact in a community-based hematological ward in an Italian Red Zone |
Giuseppe Visani, Martina Chiarucci, Barbara Guiducci, Maria Capalbo, Alessandro Isidori |
69 |
[GO] |
2020―Jun―12 |
SARS-CoV-2 infection in children with febrile neutropenia |
Victoria Flores, Raquel Miranda, Laura Merino, Carmen González, Cristina Serrano, Moises Solano, et al. (+6) Jessica Herrera, Paulina González, Genesis Ruiz, Ricardo Saldaña, Ahtziri Cárdenas, Lénica A. Chávez-Aguilar |
70 |
[GO] |
2020―Jun―11 |
Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection |
Michele Merli, Walter Ageno, Fausto Sessa, Marco Salvini, Domenica Caramazza, Barbara Mora, et al. (+4) Agostino Rossi, Cristina Rovelli, Francesco Passamonti, Paolo Grossi |
71 |
[GO] |
2020―Jun―04 |
Severe exacerbation of immune thrombocytopenia and COVID-19: the favorable response to corticosteroid-based therapy-a case report |
Zhiliang Hu, Wei Chen, Wenyan Liang, Chuanjun Xu, Wenkui Sun, Yongxiang Yi |
72 |
[GO] |
2020―Jun―03 |
Hematological findings in coronavirus disease 2019: indications of progression of disease |
Xiaoqing Liu, Run Zhang, Guangsheng He |
73 |
[GO] |
2020―May―27 |
Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19 |
Nil Albiol, Rahinatu Awol, Rodrigo Martino |
74 |
[GO] |
2020―May―24 |
Fatal SARS-CoV-2 coinfection in course of EBV-associated lymphoproliferative disease |
Luca Roncati, Beatrice Lusenti, Vincenzo Nasillo, Antonio Manenti |
75 |
[GO] |
2020―May―14 |
Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)? |
Giovanni Caocci, Giorgio La Nasa |
76 |
[GO] |
2020―May―08 |
Signals of Th2 immune response from COVID-19 patients requiring intensive care |
Luca Roncati, Vincenzo Nasillo, Beatrice Lusenti, Giovanni Riva |
77 |
[GO] |
2020―Apr―15 |
Mechanism of thrombocytopenia in COVID-19 patients |
Panyang Xu, Qi Zhou, Jiancheng Xu |